BELITE BIO, INC (BLTE) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $352.93M | +1014.2% |
| 2024 | $31.68M | -64.1% |
| 2023 | $88.16M | +109.5% |
| 2022 | $42.09M | +142.7% |
| 2021 | $17.34M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $352.93M | +1014.2% |
| 2024 | $31.68M | -64.1% |
| 2023 | $88.16M | +109.5% |
| 2022 | $42.09M | +142.7% |
| 2021 | $17.34M | — |